Cargando…
Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML)
In addition to spliceosome gene mutations, oncogene expression and drug resistance in AML might influence exon expression. We performed exon-array analysis and exon-specific PCR (ESPCR) to identify specific landscapes of exon expression that are associated with DEK and WT1 oncogene expression and th...
Autores principales: | Mohamed, Aminetou Mint, Balsat, Marie, Thenoz, Morgan, Koering, Catherine, Payen-Gay, Lea, Cheok, Meyling, Mortada, Hussein, Auboeuf, Didier, Pinatel, Christiane, El-Hamri, Mohamed, Dumontet, Charles, Cros, Emeline, Flandrin-Gresta, Pascale, Nibourel, Olivier, Preudhomme, Claude, Michallet, Mauricette, Thomas, Xavier, Nicolini, Franck, Solly, Françoise, Guyotat, Denis, Campos, Lydia, Wattel, Eric, Mortreux, Franck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823079/ https://www.ncbi.nlm.nih.gov/pubmed/26284582 http://dx.doi.org/10.18632/oncotarget.3898 |
Ejemplares similares
-
How mRNA is misspliced in acute myelogenous leukemia (AML)?
por: Mohamed, Aminetou Mint, et al.
Publicado: (2014) -
HTLV-1-infected CD4+ T-cells display alternative exon usages that culminate in adult T-cell leukemia
por: Thénoz, Morgan, et al.
Publicado: (2014) -
HTLV-1 modulates alternative splicing in CD4+ T cells in vivo
por: Thenoz, Morgan, et al.
Publicado: (2011) -
Tax promotes the expression of the alternative spliced isoform CD44v10 by slowing down the elongating RNA polymerase II
por: Thenoz, Morgan, et al.
Publicado: (2014) -
Alternative splicing signatures discriminate ATL cells from untransformed CD4+ counterparts deriving from HTLV-1 infected individuals
por: Thenoz, Morgan, et al.
Publicado: (2014)